A Polymorphism in theCTGFPromoter Region Associated with Systemic Sclerosis
- 20 September 2007
- journal article
- research article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 357 (12), 1210-1220
- https://doi.org/10.1056/nejmoa067655
Abstract
Systemic sclerosis (scleroderma) is a life-threatening autoimmune disease that is characterized by the presence of specific autoantibodies and fibrosis of the skin and major internal organs.Keywords
This publication has 36 references indexed in Scilit:
- All in the CCN family: essential matricellular signaling modulators emerge from the bunkerJournal of Cell Science, 2006
- Gene profiling of scleroderma skin reveals robust signatures of disease that are imperfectly reflected in the transcript profiles of explanted fibroblastsArthritis & Rheumatism, 2006
- Mechanisms and consequences of fibrosis in systemic sclerosisNature Clinical Practice Rheumatology, 2006
- Matrix Contraction by Dermal Fibroblasts Requires Transforming Growth Factor-β/Activin-Linked Kinase 5, Heparan Sulfate-Containing Proteoglycans, and MEK/ERKThe American Journal of Pathology, 2005
- Genetics of scleroderma: update on single nucleotide polymorphism analysis and microarraysCurrent Opinion in Rheumatology, 2005
- Monozygotic twins clinically discordant for scleroderma show concordance for fibroblast gene expression profilesArthritis & Rheumatism, 2005
- Systemic and cell type-specific gene expression patterns in scleroderma skinProceedings of the National Academy of Sciences, 2003
- Genome‐wide association study for regions of systemic sclerosis susceptibility in a Choctaw Indian population with high disease prevalenceArthritis & Rheumatism, 2003
- Systemic sclerosis: the susceptible host (genetics and environment)Rheumatic Disease Clinics of North America, 2003
- Preliminary criteria for the classification of systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1980